Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic combinations of RAR antagonists and RXR agonists and use thereof

Therapeutic combinations of RAR antagonists and RXR agonists and use thereof

US Patent 6130230 · Granted Oct 10, 2000

Estimated economic value: $383,131,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Branched polymers2025
Non-steroidal selective glucocorticoid receptor agonistic modulators (SEGRAMs) a2021
Method for controlling the biological activity of a protein in a vertebrate cell2016
Methods and compositions for controlling assembly of viral proteins2014
Derivatives of psammaplin A, a method for their synthesis and their uses for the2012
Compositions and methods for treating B-cell malignancies2011
White electrophosphorescence from semiconducting polymer blends2010
Transgenic mouse for targeted recombination mediated by modified Cre-ER2006
Method for the stable inversion of DNA sequence by site-specific recombination a2006
Plasmon assisted enhancement of organic optoelectronic devices2006
Transcriptional intermediary factor-22005
Transcriptional intermediary factor-22005